PRECLINICAL CANCER OF THE
Tumors in deep tissue in the colon or pancreas are usually managed by invasive resections. To make those resections as effective and small as possible, suitable imaging modalities are needed to help localize and demarcate those tumors. In several preclinical studies, it was shown that optoacoustic imaging could help to localize those deeper situated tumors via high resolution 3D views and the application of targeted contrast agents with high specificity before surgery. Furthermore, detailed vascular changes in such tumors could be monitored non-invasively with RSOM, helping to understand the progression and treatment success for cancer in the digestive system.